Biogen Inc. Earnings

Biogen Inc.’s revenue fell -7.15% since last year same period to $2279.3Mn in the Q4 2025. On a quarterly growth basis, Biogen Inc. has generated -7.15% fall in its revenue since last 3-months.

Biogen Inc.’s net profit fell -118.15% since last year same period to $-48.41Mn in the Q4 2025. On a quarterly growth basis, Biogen Inc. has generated -110.38% fall in its net profits since last 3-months.

Biogen Inc.’s net profit margin fell -119.55% since last year same period to -2.12% in the Q4 2025. On a quarterly growth basis, Biogen Inc. has generated -111.18% fall in its net profit margins since last 3-months.

Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.03 - a 88.2% jump from last quarter’s estimates.

Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.03.

Biogen Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Biogen Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.